Literature DB >> 2413968

Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability.

W A Banks, A J Kastin.   

Abstract

Eighteen peptides were examined for penetration across the blood-brain barrier (BBB) in rats. Iodinated peptides were injected via the carotid artery and 5 sec later the rats were decapitated. The results were expressed as a brain to blood ratio. The results showed that small amounts of most peptides enter the brain. The octanol coefficient, a measurement of lipophilicity, was a good predictor of penetration for most peptides. The low molecular weight, N-tyrosinated peptides (leucine-enkephalin, methionine enkephalin, N-Tyr-MIF-1, and N-Tyr-FMRF), that have been shown to be transported out of the brain by a saturable, carrier-mediated system, had much lower penetration rates than those predicted by their octanol coefficients. Molecular weight, percent of unbound peptide, total charge, net charge, and absolute charge were not good predictors of peptide penetration. Pretreatment of the rats with IP aluminum, which has been suggested to increase lipophilic permeability of the BBB, enhanced passage of 15 of the 18 peptides but not radioiodinated serum albumin or radioactive red blood cells. Thus, of the various physicochemical characteristics of peptides tested here, lipophilicity was most important in determining penetration of peptides across the BBB. However, the existence of one class of peptides that deviates from this trend (those of low molecular weight with an N-tyrosine) and the variability among the remaining peptides suggests that other, unidentified factors may be important in the prediction of peptide penetration across the BBB.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413968     DOI: 10.1016/0361-9230(85)90153-4

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  57 in total

1.  Permeability of porcine blood brain barrier to somatostatin analogues.

Authors:  Gert Fricker; Stephanie Nobmann; David S Miller
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 2.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

3.  Insulin detemir is not transported across the blood-brain barrier.

Authors:  William A Banks; John E Morley; Jessica L Lynch; Kristin M Lynch; Arshag D Mooradian
Journal:  Peptides       Date:  2010-09-22       Impact factor: 3.750

4.  Glucagon signalling in the dorsal vagal complex is sufficient and necessary for high-protein feeding to regulate glucose homeostasis in vivo.

Authors:  Mary P LaPierre; Mona A Abraham; Jessica T Y Yue; Beatrice M Filippi; Tony K T Lam
Journal:  EMBO Rep       Date:  2015-08-19       Impact factor: 8.807

Review 5.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

Review 6.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

Review 7.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

8.  Neuropeptide substance P improves water maze performance in aged rats.

Authors:  R U Hasenöhrl; J P Huston; T Schuurman
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 9.  Delivering peptides to the central nervous system: dilemmas and strategies.

Authors:  W A Banks; A J Kastin; C M Barrera
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

10.  Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor.

Authors:  K Akhilender Naidu; Richard C Karl; Kamatham A Naidu; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.